ask="19.49"
ask_size="200"
average_daily_volume="143002"
bid="16.05"
bid_size="400"
book_value="6.55"
change="+1.41"
change_from_200_day_moving_average="2.62"
change_from_50_day_moving_average="2.00"
change_from_52_week_high="-9.50"
change_From_52_week_low="5.98"
change_in_percent="+8.50%"
close="18.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-2.91"
eps_estimate_next_quarter="-0.73"
eps_estimate_next_year="-3.05"
ex_dividend_date="N/A"
float_shares="11787000"
high="18.40"
high_52_weeks="27.50"
last_trade_date="1/4/2017"
last_trade_price="18.00"
last_trade_size="19460"
last_trade_time="4:00pm"
low="16.63"
low_52_weeks="12.02"
market_capitalization="395.68M"
moving_average_200_day="15.38"
moving_average_50_day="16.00"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="33.57"
open="16.63"
pe_ratio="N/A"
peg_ratio="-0.08"
percent_change_from_200_day_moving_average="+17.02%"
percent_change_from_50_day_moving_average="+12.50%"
percent_change_from_52_week_high="-34.55%"
percent_change_from_52_week_low="+49.75%"
previous_close="16.59"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.53"
price_per_sales="344.36"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="29.71"
stock_exchange="NGM"
symbol="ADMS"
volume="311804"
weeks_range_52="12.02 - 27.50"
